Company Filing History:
1 out of 5 
1 out of 1 
1 out of 33 
Years Active: 2014-2021
Title: Zlatko Janeba: Innovator in Pyrimidine Compounds
Introduction
Zlatko Janeba is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrimidine compounds. With a total of 2 patents, his innovations focus on compounds that have therapeutic potential in treating inflammatory and cancer diseases.
Latest Patents
Janeba's latest patents include two significant inventions. The first patent describes polysubstituted pyrimidines that inhibit the formation of prostaglandin E2. This invention outlines a method of production for these compounds, which effectively lower the production of prostaglandin E without negatively affecting cell viability. The second patent presents pyrimidine compounds that simultaneously inhibit the formation of nitric oxide and prostaglandin E2. These compounds also maintain cell viability while reducing the production of these inflammatory factors.
Career Highlights
Throughout his career, Zlatko Janeba has worked with esteemed institutions such as the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences and the Institute of Experimental Medicine of the Czech Academy of Sciences. His research has significantly advanced the understanding of pyrimidine compounds and their applications in medicine.
Collaborations
Janeba has collaborated with notable colleagues, including Zdenek Zidek and Petr Jansa. These partnerships have contributed to the successful development of his innovative compounds.
Conclusion
Zlatko Janeba's work in the field of pyrimidine compounds showcases his dedication to advancing medical science. His patents reflect a commitment to developing effective treatments for inflammatory and cancer diseases.